Status: retired, Not sufficiently defined by necessary conditions definition status. Date: 05-Aug 2020. Module: SNOMED CT United Kingdom drug extension module
Descriptions:
| Id | Description | Lang | Type | Status | Case? | Module |
| 373701000001119 | Lanadelumab | en | Synonym | Active | Entire term case sensitive | SNOMED CT United Kingdom drug extension module |
| 373721000001114 | Lanadelumab (substance) | en | Fully specified name | Active | Entire term case sensitive | SNOMED CT United Kingdom drug extension module |
| Outbound Relationships | Type | Target | Active | Characteristic | Refinability | Group | Values |
| Lanadelumab | Is a | Substance with kallikrein inhibitor mechanism of action | false | Inferred relationship | Existential restriction modifier |
| Inbound Relationships | Type | Active | Source | Characteristic | Refinability | Group |
| Lanadelumab 300mg/2ml solution for injection vials | Has specific active ingredient | False | Lanadelumab | Inferred relationship | Existential restriction modifier | |
| Takhzyro 300mg/2ml solution for injection vials (Takeda UK Ltd) | Has specific active ingredient | False | Lanadelumab | Inferred relationship | Existential restriction modifier | |
| Takhzyro 300mg/2ml solution for injection vials (Takeda UK Ltd) 1 vial | Has specific active ingredient | False | Lanadelumab | Inferred relationship | Existential restriction modifier | |
| Lanadelumab 300mg/2ml solution for injection vials 1 vial | Has specific active ingredient | False | Lanadelumab | Inferred relationship | Existential restriction modifier |
This concept is not in any reference sets
FHIR